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Abstract
Background: Calcium signaling plays an important role in B lymphocyte survival and activation,
and is critically dependent on the inositol-1,4,5-tris-phosphate-induced release of calcium stored in
the endoplasmic reticulum (ER). Calcium is accumulated in the ER by Sarco/Endoplasmic Reticulum
Calcium ATPases (SERCA enzymes), and therefore these enzymes play an important role in ER
calcium homeostasis and in the control of B of cell activation. Because Epstein-Barr virus (EBV) can
immortalize B cells and contributes to lymphomagenesis, in this work the effects of the virus on
SERCA-type calcium pump expression and calcium accumulation in the endoplasmic reticulum of
B cells was investigated.
Results: Two Sarco-Endoplasmic Reticulum Calcium transport ATPase isoforms, the low Ca2+-
affinity SERCA3, and the high Ca2+-affinity SERCA2 enzymes are simultaneously expressed in B
cells. Latency type III infection of Burkitt's lymphoma cell lines with immortalization-competent
virus expressing the full set of latency genes selectively decreased the expression of SERCA3
protein, whereas infection with immortalization-deficient virus that does not express the EBNA2
or LMP-1 viral genes was without effect. Down-modulation of SERCA3 expression could be
observed upon LMP-1, but not EBNA2 expression in cells carrying inducible transgenes, and LMP-
1 expression was associated with enhanced resting cytosolic calcium levels and increased calcium
storage in the endoplasmic reticulum. Similarly to virus-induced B cell immortalisation, SERCA3
expression was also decreased in normal B cells undergoing activation and blastic transformation
in germinal centers of lymph node follicles.
Conclusion: The data presented in this work indicate that EBV-induced immortalization leads to
the remodelling of ER calcium homeostasis of B cells by LMP-1 that copies a previously unknown
normal phenomenon taking place during antigen driven B cell activation. The functional remodelling
of ER calcium homeostasis by down-regulation of SERCA3 expression constitutes a previously
unknown mechanism involved in EBV-induced B cell immortalisation.
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Endoplasmic reticulum (ER) calcium homeostasis plays
an important role in the control of cell activation [1,2].
Calcium release from the ER by the second messenger D-
myo-inositol-1,4,5-tris-phosphate (IP3) upon activation of
receptors such as the B-cell or chemokine receptors, com-
bined with ensuing calcium influx across the plasma
membrane (store operated calcium entry, SOCE), leads to
the activation of key calcium-dependent enzymes
involved in cell activation such as various protein kinase
C isoforms, calcineurin or calmodulin dependent kinases
[2-6]. Because these enzymes critically modulate the activ-
ity of transcription factors such as NF-κB, NF-AT or AP1,
calcium signalling, initiated by calcium release from the
ER, plays important roles in B cell survival, maturation
and activation. In addition, normal ER calcium homeos-
tasis is also required for the post-translational modifica-
tions/chaperoning of nascent immunoglobulin
molecules taking place in the organelle, a phenomenon
that is also involved in the regulation of B cell maturation
and plasma cell survival [7-9].
Because calcium accumulation into the endoplasmic retic-
ulum (ER) is accomplished by Sarco/Endoplasmic Reticu-
lum Calcium ATPases (SERCA-type calcium pumps) that
generate a strong calcium concentration gradient between
the cytosol (low nanomolar) and the ER lumen (high
micromolar), precisely regulated SERCA activity is essen-
tial for normal cell function and survival [10]. SERCA-type
calcium pumps are encoded by three genes (SERCA1, 2
and 3) that give rise by alternative splicing to several
isoenzymes. Whereas SERCA1 is expressed in skeletal
muscle, and the SERCA2a isoform is found in cardiac
muscle, SERCA2b expression is ubiquitous. In several cell
types such as T lymphocytes, myeloid cells, megakaryo-
cytes and platelets, as well as in colon and gastric epithe-
lial cells SERCA2b is co-expressed with SERCA3 [11-18].
Whereas the basic biochemical function (i.e. calcium
transport into the ER) is shared among SERCA2 and
SERCA3 isoenzymes, the calcium affinity of SERCA3 is
significantly inferior to that of SERCA2b [10,19-22]. The
co-expression of SERCA2b and SERCA3 within the same
cell is thus involved in the fine regulation of the calcium
uptake characteristics of the ER in a cell type-dependent
manner.
Epstein-Barr virus, a human gammaherpesvirus can
immortalize primary naïve B lymphocytes, leading to the
establishment of permanently growing lymphoblastoid
cell lines (LCL). In addition, the virus is etiologically
involved in the formation of several types of malignancies
such as Burkitt's lymphoma, lymphomas of immunocom-
promised individuals, some NK/T lymphomas, lympho-
matoid granulomatosis, pyothorax-associated
lymphoma, Hodgkin's lymphoma, as well as gastric and
nasopharyngeal carcinomas (for a comprehensive review
of EBV biology see [23]). EBV-induced immortalization of
B cells into LCLs, as well as malignant transformation are
linked to the viral latent membrane protein-1 (LMP-1),
the expression of which is under the control of the EBNA2
virus encoded protein. LMP-1 displays great functional
homology with activated CD40 normally expressed on B
cells [23,24]. LMP-1 constitutively activates a variety of
signalling cascades including NF-κB, ERK, JNK, and p38
MAP kinase, as well as the Akt-PI3K pathway, is responsi-
ble for the phenotypic changes observed during conver-
sion of B cells into LCLs, and is a bona fide transforming
oncogene in various experimental systems [23,25].
EBV infection, as well as normal lymphocyte activation
have been shown to lead to increased resting cytosolic cal-
cium concentration [26,27]. Calcium release from the ER
into the cytosol through IP3 receptor calcium channels is
essential for B cell function at various stages of B cell dif-
ferentiation [27-29]. Calcium-dependent cell activation is
initiated by calcium release from the ER through IP3
receptors [1,2], and is greatly amplified by subsequent cal-
cium influx from the extracellular space through Orai1-
type store-operated calcium channels that are opened by
decreased calcium levels in the ER lumen [4,30]. Because
calcium release is critically dependent on ER calcium
accumulation by SERCA-type enzymes, and because
SERCA activity is instrumental in the shaping of the
amplitude, the intensity and the duration of cellular cal-
cium signals [31-33] and therefore of cell activation [34-
36], in this work we investigated endoplasmic reticulum
calcium pump expression and function in various EBV-
infected B cells, in cells that express transgenic key EBV
proteins such as LMP-1, and compared their effects to nor-
mal B cell activation in situ.
Results
Decreased SERCA3 expression in stably EBV-infected 
Burkitt's lymphoma cell lines
BL-30 and BL-41 belong to a set of EBV-negative Burkitt's
lymphoma cell lines that have been previously estab-
lished [37], and subsequently infected with immortaliz-
ing, as well as non-immortalizing EBV strains (B95–8 and
P3HR-1, respectively) in vitro. Infection led to the estab-
lishment of latently infected cell lines [38]. Whereas B95–
8-infected cells express the whole set of type III latency
genes including EBNA2 and LMP-1, P3HR-1-infected cells
lack LMP-1 expression due to a deletion in the sequence
of EBNA2 that transactivates LMP-1 [38]. In order to
investigate the effect of virus on calcium pump expres-
sion, equal amounts of total protein extracts from non-
infected and infected cells were analysed for SERCA2 and
SERCA3 expression in a Western immunoblot format
with the IID8 and PLIM430 monoclonal antibodies,
respectively. As shown in Fig. 1, infection with the B95–8Page 2 of 14
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Decreased SERCA3 expression in Burkitt's lymphoma cell lines infected with immortalization-competent Epstein-Barr virusFigure 1
Decreased SERCA3 expression in Burkitt's lymphoma cell lines infected with immortalization-competent 
Epstein-Barr virus. Panel A: Total cellular protein extracts from the BL-30 (lanes 1–3) and BL-41 (lanes 4–6) cell lines free of 
EBV (lanes 1,4) or chronically infected with the P3HR-1 (lanes 2,5) or the B95–8 (lanes 3,6) EBV strain were analysed by West-
ern blotting for SERCA2 (top) and SERCA3 (center) expression in parallel with the detection of LMP-1 expression (bottom). 
Panels B,C,D,E: SERCA3 and SERCA2 expression in BL-30 (Panels B and C) and BL-41 cells (Panels D and E) infected with the 
P3HR-1 (grey columns) or the B95–8 (dark columns) EBV strains, respectively, expressed as % of SERCA expression in non-
infected cells (white columns).
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cell lines (Panel A), and similar results were obtained also
with BL-2 and BL-31 cells (not shown). As shown in Pan-
els B and D, SERCA3 expression levels in BL-30 and BL-41
cells decreased to 40 +/- 3% (n = 10), and 51 +/- 5% (n =
8) after infection with the B95–8 virus when compared to
non-infected cells, whereas SERCA2 expression increased
to 223 +/- 35% (n = 6) and 150 +/- 31% (n = 5), respec-
tively. At the same time, infection with the P3HR-1 strain
had only marginal effects on the expression of SERCA pro-
teins. Importantly, LMP-1 expression could only be
observed in cells stably infected with the B95–8 virus. This
is in accordance with earlier observations indicating that
LMP-1 expression is absent in P3HR-1-infected cells [38]
as a result of lack of EBNA-2.
Decreased SERCA3 expression during the induction of 
LMP-1 expression
Given the association between decreased SERCA3 expres-
sion and LMP-1 expression in latently infected cells (Fig.
1), the effect of the direct expression of LMP-1 on SERCA3
expression was investigated using cells stably transfected
with inducible vectors coding for LMP-1. The BJAB-tTA-
LMP-1 cell line carries an LMP-1 transgene under the con-
trol of a tetracycline-repressible promoter. When the cells
are grown in the presence of tetracycline, expression of
LMP-1 is repressed, and tetracycline withdrawal results in
LMP-1 expression at levels similar to that observed in
EBV-infected cells [39]. As shown in Fig. 2, tetracycline
withdrawal in the BJAB-tTA-LMP-1 cell line resulted in a
marked and homogeneous induction of LMP-1 protein as
detected by Western blotting (Panel A) and immunocyto-
chemistry (Panel C). Induction of LMP-1 expression led to
decreased SERCA3 levels (43 +/- 4.5%, n = 5) during five
days (Panels A and B), whereas the expression of SERCA2
was not significantly affected. As a negative control, BJAB-
tTA cells, devoid of the LMP-1 transgene were used, and in
these cells tetracycline withdrawal had no effect on SERCA
expression (not shown). Induction of LMP-1 expression
led to decreased SERCA3 expression also in the BL41-
MTLM-2 cell line, in which the expression of the LMP-1
cDNA is driven by a heavy metal-inducible promoter
derived from the metallothionein gene [40]. When cells
were grown in the presence of 100 μM Zn2+ for 3 days,
SERCA3 expression was decreased when compared to
non-induced controls, similarly to that observed in BJAB-
tTA-LMP-1 cells upon tetracycline withdrawal (not
shown). It is noteworthy to add, that SERCA3 expression
was also investigated in BL41/K3 cells in which the expres-
sion of an EBNA2 transgene is driven by an estradiol-
inducible promoter [41]. However, induction of EBNA2
expression in these cells by estradiol for three days as in
[41] did not significantly modify SERCA3 expression,
indicating that LMP-1 alone is sufficient for the effect.
The effects of LMP-1 expression on endoplasmic reticulum 
calcium homeostasis
In order to establish the effects of LMP-1 expression on B
cell calcium homeostasis, resting cytosolic calcium con-
centration and endoplasmic reticulum calcium storage
capacity were measured by Indo-I spectrofluorimetry in
the BJAB-tTA-LMP-1 cell line before and after induction of
LMP-1 expression. In addition, similar experiments were
conducted on non-infected BL-30 and BL-41 Burkitt's-
lymphoma cell lines in parallel with BL-30-B95–8 and BL-
41-B95–8 cells infected with the immortalizing B95.8 EBV
strain that expresses LMP-1.
As shown in Fig. 3, induction of LMP-1 expression in the
BJAB-tTA-LMP-1 cells led to increased resting cytosolic
calcium concentrations (Panel A). Indeed, whereas the
resting cytosolic calcium concentration was 95 +/- 2 nM
(n = 5) in non-induced cells, LMP-1 induction led to a
gradual increase to 165 +/- 1 nM (n = 5) during a five days
period. LMP-1 induction was also accompanied by
increased calcium release from the ER upon full inhibi-
tion of SERCA-dependent transport by 1 μM thapsigargin.
As shown in Panel B, when calcium release from the ER
was induced by 1 μM thapsigargin in conditions where
Ca2+ is trapped in the cytosol due to the inhibition of
plasma membrane calcium pumps and Na+/Ca2+
exchange by 0.4 μM Hg2+ and replacement of extracellular
Na+ by Li+, respectively, LMP-1 expressing cells displayed
significantly enhanced calcium release from the ER, as
reflected by a higher plateau of cytosolic Ca2+ levels (157
+/- 7 nM, n = 5), in LMP-1 expressing cells (Panel B),
when compared to non-induced cells (129 +/- 7 nM, n =
5). When expressed as area under curve (AUC) values,
LMP-1 expression under these conditions led to an
approximately 24% increased calcium release when com-
pared to non-induced cells (Panel D). Increased calcium
mobilization from the ER by thapsigargin could also be
seen in LMP-1-expressing cells in the presence of extracel-
lular Na+ and in the absence of PMCA inhibition (Panel
C), indicating that the observed LMP-1-dependent
changes of cellular calcium homeostasis are also present
in the presence of active plasma membrane calcium extru-
sion. The same experiments conducted on control BJAB-
tTA cells treated identically to BJAB-tTA-LMP-1 cells, but
devoid of LMP-1 expression disclosed no changes in cellu-
lar calcium homeostasis upon treatments (not shown).
On the other hand, increased calcium storage in thapsi-
gargin-sensitive intracellular calcium pools could also be
observed, very similarly to LMP-1 induction, in cells
infected with fully competent virus that expresses LMP-1
protein. Indeed, as shown in Fig. 4, when calcium release
from the endoplasmic reticulum was induced by thapsi-
gargin in non-infected BL-30 and BL-41 cells (black
curves), and in cells infected with wild-type EBV (grey
curves), an enhanced calcium release response could bePage 4 of 14
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LMP-1 expression leads to decreased SERCA3 expressionFigure 2
LMP-1 expression leads to decreased SERCA3 expression. Panel A: BJAB-tTA-LMP-1 cells were grown in the presence 
(lanes 1,3,5,7 and 9) or absence (lanes 2,4,6,8 and 10) of 1 μg/ml tetracycline for 5 days, and SERCA2 (top), SERCA3 (center), 
as well as LMP-1 expression levels (bottom) were determined by Western blotting. Panel B: SERCA 3 (black column) and 
SERCA2 (grey column) expression in BJAB-tTA-LMP1 cells at day 5 of LMP1 expression. White column: SERCA2 or SERCA3 
expression prior induction (100%). Panel C: immunocytochemical detection of LMP-1 expression in BJAB-tTA-LMP1 cells 
before (top), and after induction (bottom) of LMP-1 expression by tetracycline withdrawal.
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Modulation of cellular calcium homeostasis by LMP-1 protein expressionFigure 3
Modulation of cellular calcium homeostasis by LMP-1 protein expression. LMP-1 expression in BJAB-tTA-LMP1 cells 
was induced by tetracycline withdrawal, and resting cytosolic calcium concentration, as well as thapsigargin-induced calcium 
release from the endoplasmic reticulum were measured. Panel A: The increase of the resting cytosolic calcium concentration in 
BJAB-tTA-LMP-1 cells during LMP-1 induction. Panels B and C: Calcium release from thapsigargin-sensitive intracellular pools 
in the presence (Panel B), and in the absence (Panel C) of inhibition of PMCA and Na+/Ca2+ exchanger activity. Black curves: 
non-induced cells, grey curves: cells at day 5 of LMP-1 induction. Panel D: The magnitude of calcium release from non-induced 
cells (black column) and in cells at day 5 of LMP-1 induction (grey column), expressed as area under curve (AUC) values of 
measurements presented in Panel B. LMP-1 induction leads to enhanced calcium release from the endoplasmic reticulum by 
thapsigargin indicating increased calcium sequestration.
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Enhanced calcium release from the endoplasmic reticulum in EBV-infected cellsFigure 4
Enhanced calcium release from the endoplasmic reticulum in EBV-infected cells. Calcium mobilisation from the 
thapsigargin-sensitive endoplasmic reticulum calcium pool in non-infected (black curves), and EBV-infected cells (grey curves) 
was measured in BL-30 (Panels A and C) and BL-41 (Panels B and D) cells. Thapsigargin-induced calcium release from the cells 
was recorded in the absence (Panels A and B), and in the presence (Panels C and D) of inhibition of PMCA and Na+/Ca2+ 
exchanger-dependent calcium extrusion across the plasma membrane. Panels E and F: Area under curve values of the plateau 
phase of calcium release obtained in Panels C and D expressed in arbitrary units (AUC). Black columns: non-infected, grey col-
umns: infected cells.
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Molecular Cancer 2009, 8:59 http://www.molecular-cancer.com/content/8/1/59observed in both cell lines in the presence of the virus.
When the experiments were performed in the absence of
inhibition of plasma membrane calcium pump and Na+/
Ca2+ exchanger activity, this could be observed as an
increased calcium peak following thapsigargin addition in
BL-30 (non-infected versus infected: 35 +/- 5 nM and 61 +/
- 10 nM, n = 3, p > 0.05), as well as BL-41 cells (non-
infected versus infected: 68 +/- 5 nM and 82 +/- 5 nM, n =
4, p = 0.056). When the same experiments were per-
formed in the presence of inhibition of PMCA and Na+/
Ca2+ exchanger function, calcium release from the endo-
plasmic reticulum occurred as a sustained plateau and was
markedly enhanced in infected cells. In fact, whereas in
non-infected BL-30 and BL-41 cells calcium levels raised
to 106 +/- 2 nM (n = 4) and 139 +/- 5 nM (n = 3), respec-
tively, in the corresponding EBV-infected cells calcium
levels attained 234 +/- 17 nM (n = 4) and 204 +/- 6 nM (n
= 3), respectively, corresponding to a highly significant (p
< 0.01) increase in infected cells. When this calcium
release was expressed as area under curve (AUC) values of
the plateau phase of the corresponding calcium fluorime-
try curves of non-infected and B95–8-infected BL-30 and
BL-41 cells, a highly significant increase of 110% and of
46% could be observed, respectively (Panels E and F).
Decreased SERCA3 expression during normal B cell 
activation in situ
EBV infection of B cells leads to the emergence of immor-
talized cell lines that actively proliferate and display a
lymphoblastoid phenotype. In order to investigate,
whether SERCA3 expression is modulated, similarly to
EBV infection, also during normal B lymphocyte activa-
tion in a physiological tissue environment in situ, immu-
nohistochemical staining for the protein was performed
in normal lymph node and colic mucosa-associated lym-
phoid follicles. In these tissues quiescent, antigen-naïve
non-stimulated small B lymphocytes reside in the mantle
zone, whereas antigen-activated large centroblasts and
centrocytes are located in germinal centers. Such a differ-
ential localization of resting and antigen-activated B cell
populations in these tissues permits their identification
on a histological basis. As shown in Fig. 5, Panel A,
SERCA3 expression in a lymph node follicle displays
marked differences: whereas the mantle zone that sur-
rounds germinal centers is strongly labelled, staining in
the germinal center is markedly weaker. As shown at
higher magnification on Panel B, whereas small lym-
phocytes residing in the mantle zone are strongly labelled,
SERCA3 expression in the germinal center activated lym-
phoblasts is markedly decreased.
In addition to a strong SERCA3 staining in colon epithe-
lium as reported earlier [11,14], a staining pattern very
similar to that observed in lymph node follicles could be
seen also in mucosa-associated lymphoid tissue in the
colon (Panel C), with a marked decrease of SERCA3
expression in germinal centers when compared to small
resting B cells located in a more luminal position.
These data taken together indicate that antigen-driven
activation of small resting B lymphocytes located in the
mantle zone into germinal center lymphoblasts is accom-
panied by a marked and homogeneous decrease of
SERCA3 expression.
Discussion
The EBV life cycle in B cells is critically regulated by cellu-
lar calcium signalling: protein kinase C and calmodulin
dependent kinase activation are key factors that determine
the transition from latency to virus replication and host
cell lysis. In experimental settings this is reflected by the
strong capacity of agents that increase cytosolic calcium
levels to induce the lytic cycle in latently infected B cells.
Indeed, calcium ionophores, such as A23187 or ionomy-
cin, are strong inducers of EBV reactivation [42].
Endoplasmic reticulum calcium homeostasis is also
involved in several mechanisms essential for normal B
lymphocyte function at various stages of differentiation.
Appropriate calcium signalling is necessary for pre-B cell
receptor, as well as B-cell receptor-dependent intracellular
signalling and lymphocyte selection/survival, differentia-
tion and antigen-dependent activation [27,28,43]. In
addition, plasmocytes, that are fully differentiated, anti-
body secreting B cells, build up large amounts of endo-
plasmic reticulum, as this organelle is involved in
immunoglobulin synthesis and maturation [44-46].
Although the importance of ER calcium homeostasis and
signalling in the control of EBV replication is clearly estab-
lished in the literature [42,47], data on the effect of EBV
on ER calcium homeostasis, and in particular on SERCA
expression and function were lacking. In this work we
show, for the first time, that SERCA expression and activ-
ity are modified by EBV in B cells in type III latency by
LMP-1. A marked decrease of SERCA3 expression could be
observed in various Burkitt's lymphoma cell lines infected
with the B95–8 EBV strain that displays full immortaliz-
ing capacity and expresses LMP-1 and EBNA2, whereas the
non-immortalizing P3HR-1 virus strain that lacks LMP-1
expression due to deletions in the sequence of the EBNA2
viral transactivator [38] was without effect. Importantly,
down-modulation of SERCA3 expression could also be
induced by the expression of LMP-1 in trans, in the
absence of any other viral elements, such as EBNA2 or
EBNA3A, 3B or 3C, in various inducible expression sys-
tems, indicating that LMP-1 alone is sufficient for SERCA3
down-modulation. LMP-1 expression led to increased
resting cytosolic calcium levels in accordance with previ-
ous observations [48] and, importantly, to increased cal-Page 8 of 14
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Immunohistochemical staining for SERCA3 protein in normal resting and activated B lymphocytesFigure 5
Immunohistochemical staining for SERCA3 protein in normal resting and activated B lymphocytes. SERCA 
expression in lymph node and mucosa associated lymphoid tissue was detected by imunohistochemistry using the PLIM430 
monoclonal anti-SERCA3 antibody with o-diaminobenzidine as a chromogen and hematoxylin counterstain. Panel A: lymph 
node follicle Panel B: mantle zone small resting B lymphocytes (lower right) and germinal center activated lymphoblasts (upper 
left). Panel C: colonic intraepithelial lymphoid follicle with germinal center.
A
B
200μm
C
50μm
200μm
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induced calcium release, indicating that LMP-1 can induce
functional changes in the ER calcium homeostasis of the
host cell. Unlike during induction of the expression of
LMP-1 cDNA, resting cytosolic calcium levels were not sig-
nificantly increased in chronically EBV-infected cells,
probably due to secondary compensatory mechanisms,
such as increased SERCA2 expression, that occur during
the establishment of latency, or due LMP-2A that has been
shown to blunt calcium mobilisation in B cells [49]. How-
ever, SERCA3 down-modulation and enhanced ER cal-
cium storage could be observed, both in Burkitt's
lymphoma cell lines infected with the prototypical,
immortalizing B95–8 EBV strain and in EBV-free cells
expressing only an LMP-1 transgene. These data taken
together show, that EBV modifies SERCA expression as
well as functional calcium accumulation into the ER of
latently infected B cells, by the LMP-1 viral oncoprotein.
LMP-1 activates several signalling pathways including NF-
κB, STATs, ERK, JNK, p38 MAPK, as well as PI3K/Akt. Due
to the simultaneous activation and cross-talk among these
regulatory mechanisms, the identification of the direct
molecular mechanism of LMP-1-induced SERCA3 down-
regulation requires further work. However, our data show,
for the first time, that the modulation of ER calcium
homeostasis is part of the cell activation program induced
by LMP-1.
The functional consequences of the modulation of SERCA
expression by EBV in B cells are complex. The various pro-
tein types involved in cellular calcium homeostasis func-
tion in a highly interconnected manner, due to the fact
that the transport activity of various SERCA and PMCA
enzymes, as well as the opening probability of IP3 recep-
tor calcium channels are regulated by the calcium concen-
tration of the cytosol or of the ER lumen. This leads to
positive, as well as negative feedback regulation that often
generate oscillatory cellular calcium signals, the frequency
and amplitude of which can selectively affect the activa-
tion of target proteins such as PKC or calcineurin [50-54].
Computer modelling of the highly dynamic interplay of
calcium pumps, channels and target enzymes, coupled to
experimental observation made on cells in which SERCA3
expression was ablated, led to the conclusion that SERCA3
function is particularly important for the shaping of the
characteristics (amplitude, frequency and duration) of
calcium oscillations [31-33,55,56]. For instance, it has
been shown, that the loss of SERCA3 expression leads to
altered glucose-induced calcium oscillations and electrical
activity that control insulin secretion in the β cells of the
endocrine pancreas [55,57]. The calcium affinity of
SERCA3 (KCa2+ ~ 1.2 μM) is significantly lower than that
of the simultaneously expressed SERCA2b isoenzyme
(KCa2+ ~0.2 μM) [19,21,22,58]. Because the variations of
cytosolic calcium levels during cell activation in the vicin-
ity of the ER lie within the range in which SERCA3 activity
is modulated by calcium, the amount of SERCA3
expressed in a cell has a major impact on the shape and
frequency of calcium signals, and therefore can determine
the state of activation of the cell, whereas SERCA2b func-
tion is more probably involved in constitutive calcium
uptake in the ER, linked to "housekeeping" functions, as
this enzyme is probably almost fully active already at rest-
ing cytosolic calcium levels.
The results presented in this paper on increased intracellu-
lar calcium pool size in the presence of EBV or LMP-1
expression are compatible with the observed decrease of
SERCA3 expression. It may be hypothesised that
decreased SERCA3 expression reflects the loss or deple-
tion of a lower affinity or leakier intracellular ER sub-com-
partment, leading to calcium accumulation into a higher
affinity, SERCA2b associated ER pool containing more
calcium releasable by SERCA inhibition. The exact struc-
tural and functional relationship between SERCA2 and
SERCA3-associated intracellular calcium pools in B cells
remains, however, to be determined.
Enhanced calcium accumulation induced by LMP-1 may
be involved in the establishment of viral latency. Because
the EBV lytic cycle can be induced by increased cytosolic
calcium levels (as observed with calcium ionophores or
during B-cell receptor activation [42,47,59]), a more strin-
gent calcium sequestration in the ER by the higher affinity
SERCA2b isoform may blunt calcium signals that would
otherwise lead to the induction of the lytic cycle. Moreo-
ver, SERCA3 has been shown earlier to be associated with
the IP3-sensitive sub-compartment of the ER in platelets
[60]. It is therefore tempting to hypothesize that the selec-
tive down-regulation of SERCA3 expression in EBV
infected B cells may correspond to decreased calcium
uptake in the IP3-sensitive intracellular calcium pool with
calcium uptake being redirected towards a SERCA2-
dependent sub-compartment of the ER. This may lead to
a state of chronic, constitutive activation of the cells and
their desensitisation for further IP3-mobilizing signals.
Although the description of the detailed mechanisms of
the involvement of ER calcium homeostasis in EBV repli-
cation and latency require further studies, our work
shows, for the first time, that ER calcium homeostasis is
modulated by EBV via LMP-1, and opens new avenues in
the understanding of the interactions taking place
between EBV and the infected lymphocyte.
SERCA3 down-modulation was observed also during nor-
mal B lymphocyte activation in lymph node, as well as in
mucosa-associated lymphoid follicles. In these tissues the
mantle zone represents small resting B lymphocytes
admixed with sparse helper and suppressor T cells,
whereas in germinal centers where antigen stimulation ofPage 10 of 14
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and centroblasts accumulate [43]. As shown in this work
by immunohistochemistry, whereas small resting B lym-
phocytes in the mantle zone express SERCA3 abundantly,
SERCA3 expression markedly decreases during antigenic
stimulation in germinal centers, indicating that SERCA3
down-modulation is part of the normal B lymphocyte
activation program, where this phenomenon is related to
antigen-driven activation and blastic transformation of B
cells. Although EBV-immortalized lymphoblastoid cells
and normal germinal center B lymphoblast display phe-
notypic differences, both cell types are activated, prolifer-
ating B cells. Down-modulation of SERCA3 expression by
EBV should be considered therefore as a previously
unknown virus-induced phenomenon taking place dur-
ing establishment of type III latency and immortalization
that mimics a normal step of B cell activation.
Conclusion
The expression of SERCA3 has recently been shown to be
modulated during differentiation in cells of colon and
gastric carcinoma, as well as various types of myeloid leu-
kaemia [11,12,14,15,61,62]. These observations indicate
that SERCA3 function is modified during the differentia-
tion process of various cell types. Interestingly, the selec-
tive down-modulation of SERCA3 expression has been
observed earlier during T lymphocyte activation [16].
When taken together with data shown in the present
work, this indicates, that the down-modulation of
SERCA3 expression is a general phenomenon during T, as
well as B lymphocyte activation, and that ER calcium
homeostasis is remodelled during viral, as well as antigen-
driven or pharmacologically induced activation of both
lymphoid lineages. In addition to its interest for a more
detailed understanding of the biology of EBV-induced B
cell immortalisation, our data suggest, that ER calcium
homeostasis may constitute a new potential target for the
modulation of virus-induced activation and immortaliza-
tion of B cells by, for example, the direct pharmacological
modulation of SERCA activity. In addition, SERCA3 may
be useful as a new phenotypic marker for the detection of
the acquisition of an activated lymphocyte phenotype
during EBV-induced immortalization. As SERCA3 down-
modulation is downstream of functionally active LMP-1,
SERCA3 immunohistochemistry may also be a useful tool
to characterize lymphomas by reflecting the involvement
of LMP-1 in the process of tumorigenesis.
Methods
Cell culture
Cells were grown at 37°C in a humidified cell culture
incubator in an atmosphere of air containing 5% CO2 in
RPMI-1640 medium supplemented with 2 mM
glutamine, 2 mM alanyl-L-glutamine and 10% heat-inac-
tivated fetal calf serum (complete RPMI medium). Cell
culture reagents were from Lonza, Verviers, Belgium.
Induction of LMP-1 expression by tetracycline withdrawal
BJAB-tTA-LMP-1 cells were grown in complete RPMI
medium supplemented with 2 mg/ml G418 and 0.5 mg/
ml hygromycin B (both purchased from Sigma-Aldrich
France) and 1 μg/ml tetracycline (Fluka, Germany) as
described earlier [39]. Exponentially growing cells cul-
tured in the presence of 1 μg/ml tetracycline were washed
as follows: after centrifugation the cell pellet was resus-
pended in 10 ml complete medium containing 10% fetal
calf serum without tetracycline, transferred into a new 50
ml tube, supplemented with 35 ml serum-free RPMI-1640
medium and centrifuged again. This washing step was
repeated three times. Thereafter cells were resuspended in
complete RPMI culture medium without tetracycline at an
initial density of 2 × 105 cells/ml. During the last one or
two passages preceding induction of LMP-1 expression
and during induction by tetracycline withdrawal, selec-
tion antibiotics were omitted.
Induction of LMP-1 expression by zinc
BL41-MTLM-2 cells [40] grown in complete RPMI
medium in the exponential phase of growth were centri-
fuged and resuspended at an initial density of 3 × 105
cells/ml in complete RPMI medium. After one hour pre-
incubation at 37°C in a cell culture incubator, 100 μM
ZnCl2 (Sigma-Aldrich France, Saint-Quentin Fallavier)
was added from a 100-fold concentrated sterile-filtered
stock solution. EBNA2 expression was induced in BL41/
K3 cells that carry an estradiol-inducible EBNA2 construct
as described in [41].
Sample preparation and Western blotting
This was done essentially as described in [11]. Briefly,
after treatments cells were harvested by centrifugation,
resuspended in 1 ml ice cold NaCl (150 mM) and trans-
ferred to round-bottom 2 ml Eppendorf tubes, centrifuged
and washed again by centrifugation with 1 ml ice cold
NaCl solution. Cell pellet was thereafter resuspended in
ice cold 5% trichloroacetic acid and kept at 4°C overnight.
The protein precipitate was centrifuged at 12000 × g for 10
minutes at 4°C and supernatant was removed. The pro-
tein pellet was thereafter dissolved in lysis buffer at 30 mg
TCA-precipitated protein pellet/ml lysis buffer on a hori-
zontal shaking platform and thereafter stored at -80°C.
SDS-polyacrylamide gel electrophoresis (60 μg total cellu-
lar protein per well) in 8% (for SERCA pumps) and 10%
(for LMP-1) gels and transfer onto nitrocellulose mem-
branes was done as described in [11,14]. The presence of
equal amounts of total protein per lane was controlled by
Ponceau S staining and densitometry as described previ-
ously [11,14]. SERCA2 and SERCA3 expression was
detected using the IID8 and the PLIM430 antibodies,Page 11 of 14
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grams were obtained using the Enhanced Chemilumines-
cence (ECL) reagent kit of Amersham and were
quantitated with the ScionImage software (Scion Corp.
CA). Acquisition and quantitative analysis of SERCA sig-
nals by Western blotting has been described earlier in
detail [11,14,15]. LMP-1 was detected similarly by West-
ern blotting using an anti-LMP monoclonal antibody
cocktail (Clones CS.1–4, Code N° M 0897) of DakoCyto-
mation, Denmark.
Immunohistochemistry
Detection of SERCA3 protein in tissues was performed
exactly as described in detail [11]. Briefly, after rehydra-
tion 5 μm thick acetone fixed frozen tissue sections were
incubated with Tris-buffered saline supplemented with
5% non-fat milk powder and 0.1% Tween-20 (blocking
solution) to inhibit non-specific protein binding, fol-
lowed by incubation with the PLIM430 anti-SERCA3
monoclonal antibody (1 μg/ml) in the same solution.
After two cycles of washing with water and blocking solu-
tion, antigen binding was detected using biotinylated
anti-mouse IgG antibody and avidin-biotin-peroxydase
complex (Vectastain ABC kit; Vector Laboratories, Burlin-
game, CA). Signal was revealed with 3,3'-diaminobenzi-
dine as chromogen, and slides were counterstained with
hematoxylin. Omission of the PLIM430 primary anti-
body, replacement by isotype-matched irrelevant anti-
body or normal mouse IgG were used as negative controls,
and these gave no staining. Strong positive staining of vas-
cular endothelial cells, present in the sections and known
to express SERCA3 [21,63-66] served as internal positive
control.
Immunocytochemistry for LMP-1 expression was per-
formed on BJAB-tTA-LMP-1 cells before and after induc-
tion of LMP-1 expression by tetracycline withdrawal. Cells
were washed with PBS by centrifugation, resuspended in
PBS and cell smears were made on poly-lysine coated
microscope slides and dried on air overnight. After fixa-
tion in acetone (10 min. at room temperature), slides
were rehydrated and stained with a cocktail of anti-LMP
monoclonal antibodies (Clones CS.1–4, Code N° M
0897, DakoCytomation, Denmark) according to the
instructions of the manufacturer, using an ABC avidin-
biotin-peroxydase system with 3,3'-diaminobenzidine as
chromogen, and were counterstained with hematoxilin.
Photographs of cells were obtained using a Leica micro-
scope and a Nikon Coolpix 950 digital photographic cam-
era.
Calcium fluorimetry
Cytosolic ionized free calcium concentration ([Ca2+]cyt)
was measured by a fluorimetric ratio technique [67]. Cells
were centrifuged and resuspended at a density of 106 cells/
ml in phosphate-buffered saline (PBS) supplemented
with 1 mg/ml bovine serum albumin and incubated in the
dark with 4 μM Indo-1 AM for one hour at room temper-
ature under slow agitation. Cells were then centrifuged
and resuspended in calcium-free Hanks' buffered saline
solution (HBS; 135 mM NaCl, 5.9 mM KCl, 1.2 mM
MgCl2, 11.6 mM Hepes, 11.5 mM glucose adjusted to pH
7.3 with NaOH) prior measurements. After centrifuga-
tion, 0.5 to 1 × 106 cells were suspended in 3 ml HBS in a
quartz cuvette and inserted into a Shimadzu RF1501 spec-
trofluorimeter equipped with a stirring apparatus and a
thermostatted (37°C) cuvette holder, and connected to a
PC computer. Ultraviolet light at 360 nm was used for
excitation of Indo-1, and emission at 405 and 480 nm was
recorded in time before and after addition of reagents as
indicated in figures. Background and autofluorescence of
the cell suspensions were subtracted from the recordings.
Maximum Indo-1 fluorescence (Fmax) was obtained by
adding 1 μM ionomycin to the cell suspension in the pres-
ence of 10 mM CaCl2, and minimum fluorescence (Fmin)
was determined without added calcium in the presence of
5 mM EGTA. Measurements of resting cytosolic calcium
concentrations in the presence of extracellular calcium
were performed in HBS supplemented with 1 mM CaCl2.
Cytosolic calcium concentrations were calculated accord-
ing to the equation [Ca2+]cyt = Kd(R-Rmin)/Rmax-R), where
Kd is the apparent dissociation constant of the Indo-1-cal-
cium complex (230 nM), and R is the ratio of fluorescence
values (F) measured at 405 and 480 nm (R = F405/F480).
In appropriate experiments, inhibition of the Na+/Ca2+
exchangers was obtained by replacement of all Na+ by Li+
in the HBS bath solution, and plasma membrane calcium
pump activity was inhibited by 0.4 μM HgCl2 [68].
Statistical analysis
Data are presented as the mean +/- SEM and correspond
to at least three independent experiments; the number of
experiments performed is indicated in brackets. Statistical
analysis was performed using Student's paired t-test.
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